Genocea Biosciences (GNCA US)

Genocea Biosciences, Inc. operates as a biotechnology company. The Company develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. Genocea Biosciences uses priority identification platform to build a pipeline of immunotherapies for genital herpes and neoantigen cancer vaccine.